## **Core Concept**
Trisomy 21, also known as Down syndrome, is a genetic disorder caused by the presence of an extra copy of chromosome 21. Ultrasound (USG) findings play a crucial role in the prenatal detection of this condition. Various markers can be identified during an ultrasound scan that may suggest an increased risk of Trisomy 21.

## **Why the Correct Answer is Right**
The correct answer, **nuchal translucency (NT)**, is considered the most sensitive ultrasound marker for Trisomy 21. Nuchal translucency refers to the thickness of the fluid-filled space at the back of the fetus's neck, measured between 11 and 14 weeks of gestation. An increased NT thickness is associated with an elevated risk of Trisomy 21, as well as other chromosomal abnormalities and cardiac defects. The measurement of NT is part of the combined screening test, which also includes maternal age, gestational age, and biochemical markers (such as free beta-hCG and PAPP-A).

## **Why Each Wrong Option is Incorrect**
- **Option A:** While certain ultrasound markers like nasal bone absence or hypoplasia can be associated with Trisomy 21, they are not as sensitive or specific as nuchal translucency.
- **Option B:** Other markers, such as **tricuspid regurgitation** or **ductus venous flow**, can also be indicators but are not as universally accepted or as sensitive as NT for initial screening.
- **Option C:** Similarly, **increased umbilical cord echogenicity** or other findings might be associated with Trisomy 21 but are not the most sensitive or commonly used markers for screening.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that the **nuchal translucency (NT) scan** should be performed between 11 and 14 weeks of gestation, and the measurement should be taken with the fetus in a neutral position to ensure accuracy. An NT thickness of 3.5 mm or greater is generally considered increased and warrants further evaluation.

## **Correct Answer:** . nuchal translucency.